구강암 유전자 치료를 위한 재조합 HSCC-1 아데노바이러스의 개발 = CONSTRUCTION OF RECOMBINANT HSCC-1 ADENOVIRUS VECTOR FOR ORAL CANCER GENE THERAPY

다국어 초록 (Multilingual Abstract)

In spite of the ongoing advances, standard therapies for oral cancer still has some limitations in efficacy and in ability to prolong survival rate of advanced disease and result in significant functional defect and severe cosmetic deformity. Currently gene therapy using tumor suppressor gene is considered as a potent candidate for new therapeutic approaches that can improve efficacy and reduce complications. The purpose of this research is to identify the role of adenoviral vector to transfer HCCS-1 tumor suppressor gene in oral cancer cells and to find out whether there is a possibility for it to serve in the field of gene therapy. The human SCC-25 cell line was used for transfection. To determine the efficiency of the adenovirus as a gene delivery vector cell line was transduced with LacZ gene and analysed with X-gal staining. Northern blot was performed to confirm the tranfection with HSCC-1 gene and cell viability was assessed by cell cytotoxicity assay. We had successfully construct the recombinant HSCC-1 adenovirus(Ad5CMV-HCCS-1). DNA extracted from Ad5CMV-HCCS-1 revealed HCCS-1 gene is incorporated. The transduction efficiencies were over than 50% of SCC-25 cells with a MOI of 2 and over 95% with a MOI of 50. Northern blot analysis showed that a single 0.6kb mRNA transcript was expressed in Ad5CMV-HCCS-1 transduced SCC-25 cells. There was no or very low transcription HCCS-1 mRNA in wild and Ad5CMV-LacZ transduced SCC-25 cells. Cells transduced with Ad5CMV-HCCS-1 showed significant growth inhibition. By day 6, Ad5CMV-HCCS-1 treated cell count was decreased to 30% of mock-infected cells, while that of Ad5CMV-LacZ treated cells was 90% of mock-infected cells (p<0.05). Finally, these result suggest that the Ad5CMV-HCCS-1 has potential as a gene therapy tool for oral cancer.

참고문헌 (Reference)

1 "자궁경부암 치료에서 p53 종양억제 유전자 플라스미드와 아데노바이러스를 이용한 유전자 치료법의 개발" 42 : 2019-, 1999

2 "신경교종 세포주에서 아데노바이러스를 벡터를 이용한 wild-type p53 유전자의 전달효과" 30 : 1026-, 1998

3 "is downregulated in human cancers and induces apoptosis in cervical cancer" Candidate tumor suppressor -1, 2002

4 "Viral vectors for gene therapy" 16 : 35-, 1998

5 "Variability of adenovirus receptor density influences gene transfer efficiency and therapeutic response in head and neck cancer" 5 : 4175-, 1999

6 "Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultures from human squamous cell carcinomas" 41 : 1657-, 1981

7 "Tumor suppressor genes studied by cell hybridization and chromosome transfer" 7 : 826-, 1993

8 "Trophic effects of substance P and beta-amyloid peptide on dibutyryl cyclic AMP-differentiated human leukemic" take (take): -60, 1995

9 "Thymidine Kinase 유전자가 삽입된 재조합 아데노 바이러스와 Ganciclovir에 의한 자궁경부암 세포주의 시험관내 성장억제" 14 : 195-, 2003

10 "The relapse patterns and outcome of postoperative recurrent tongue cancer" 55 : 827-, 1997

11 "The Cambrian period of nonviral gene delivery" 1998

12 "Stable expression of the wild-type p53 gene in humna lung cancer after retrovirus-mediated gene transfer" 4 : 617-, 1993

13 "Simplified system for generating recombinant adenovirus" 95 : 2509-, 1998

14 "Seletive replication and oncolysis in p53 mutant tumors with ONYX-015 in patients with advanced head and neck cancer" 2000

15 "Salvage management for recurrent squamous cell carcinoma of the oral cavity" 22 : 34-, 200

16 "Recombinant HCCS-1 adenovirus preparation and confirmation by PCR DNA was extracted from Ad5CMV-HCCS-1 by Hirt DNA extraction method and compared with plasmid Adtn-HCCS-1 6kb HCCS-1 gene by PCR" -1 0,

17 "Phase III trial of modulation of cisplatin/fluorouracil chemotherapy by interferon alfa-2b in patients with recurrent or metastatic head and neck cancer" 1998

18 "Improvement of transduction efficiency of recombinant adenovirus vector conjugated with cationic liposome for human oral squamous cell carcinoma cell line" 601-, 2003

19 "Immune responses to adenovirus and adeno-associated virus in humans" 6 : 1574-, 1999

20 "High-efficiency gene transfer and high-level expression of wild-type p53 in human lung cancer cells mediated by recombinant adenovirus" 1 : 5-, 1994

21 "Growth suppression of human head and neck cancer cells by the introduction of a wild-type p53 gene via a recombinant adenovirus" 54 : 3662-, 1994

22 "Gene therapy-it's potential in the management of oral cancer" 3 : 957-, 1996

23 "Gene therapy for the treatment of oral squamous cell carcinoma" 82 : 11-, 2003

24 "Gene therapy for head and neck cancer" 34 : 157-, 1998

25 "Development and application of adenoviral vectors for gene therapy of cancer" 6 : 113-, 1999

26 "Characteristics of a human cell line transformed by DNA from human adenovirus type 5" 36 : 59-, 1977

27 "Cancer gene therapy" 7 : 421-, 1998

28 "Apoptosis induced in human osteosarcoma cells is one of the mechanims for the cytocidal effect of Ad5CMV-p53" 2 : 9-, 1995

29 "Adenovirus-mediated wild-type p53 gene transfer as a surgical adjuvant in advanced head and neck cancers" 5 : 1715-, 1999

30 "Adenovirus transfer of HPV 16 E6/E7 antisense RNA to human cervical cancer cells" 63 : 219-, 1996

31 "A simple techniques for the rescue of early region 1 mutations into infectious human adenovirus type 5" 163 : 614-, 1988